Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/22/2025

Propranolol Therapy Guidelines

Cardiovascular Indications

  • The American College of Cardiology recommends propranolol for symptomatic patients with hypertrophic cardiomyopathy, particularly those with exertional gradients, with a dosage range of up to 480 mg per day 1
  • For cardiac arrhythmias, propranolol is used for rate control, particularly when sympathetic tone is elevated, with IV dosing of 1-3 mg every 5 minutes to a total of 5 mg, and oral immediate-release dosing of 10-40 mg every 6 hours 2
  • Propranolol provides rate control in atrial fibrillation through slowing of sinus rate and increased AV nodal refractoriness, with oral extended-release dosing of 60-160 mg every 12 hours 2

Neurological and Psychiatric Indications

  • For situational/performance anxiety, propranolol is effective at a dose of 10-20 mg taken 30-60 minutes before the anxiety-provoking event, with a maximum single dose of 40 mg 3
  • For ongoing anxiety, propranolol is typically started at 40 mg twice daily, with a typical effective range of 80-160 mg daily in 2 divided doses 3

Dermatologic Indication

  • The American Academy of Pediatrics recommends propranolol as the treatment of choice for infantile hemangiomas requiring systemic therapy, with a dosing range of 2-3 mg/kg per day, unless comorbidities or adverse effects necessitate lower doses 4
  • A regimen of 3 mg/kg per day for 6 months showed superior results, with complete or nearly complete resolution in 60% of patients versus 4% with placebo 4

Critical Safety Considerations

  • The American Heart Association recommends avoiding routine combination of propranolol with non-dihydropyridine calcium channel blockers due to increased risk of bradycardia and heart block 3
  • Propranolol is contraindicated in patients with second or third-degree heart block, decompensated heart failure, asthma or obstructive airway disease, cardiogenic shock, sinus node dysfunction without pacemaker, and hypotension 3
  • Gradual taper over 1-3 weeks is mandatory when discontinuing propranolol after chronic use to prevent rebound hypertension, tachycardia, or angina 3
  • In diabetic patients, propranolol masks symptoms of hypoglycemia, requiring careful monitoring 2, 3